Navigation Links
Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators
Date:9/21/2009

DEERFIELD, Ill., Sept. 21 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy. The national, year-long program connects new science teachers to a range of tools and resources, while providing the support needed to build a strong foundation for science in their classrooms. The 2009 Astellas-sponsored science teachers, known as Astellas-NSTA Fellows, include 15 new science educators from middle and high schools in Chicago and the surrounding Cook, Kane, Lake, McHenry and Tazewell counties.

"As a young science teacher I've found that juggling my responsibilities, while at the same time instilling in students an interest in science, can be a daunting task," said Alex Mendralla, an eighth grade teacher at Palombi Middle School in Lake Villa, IL. "I am extremely excited to be a part of an amazing program that understands those struggles and offers solutions to the various frustrations that new science educators encounter."

Headquartered in Deerfield, IL, Astellas' support of the NSTA and the New Science Teacher Academy is one of the key initiatives the company is undertaking to support the local community and the advancement of science in the classroom.

"Science is not only the foundation of our business, it's our passion. A renewed and continued interest in the field -- particularly among our youth -- is what will keep fresh ideas and innovation moving forward," said Seigo Kashii, president and CEO of Astellas Pharma US, Inc. "Our ongoing commitment to the NSTA New Science Teacher Academy reflects our overall goal of fostering the advancement of, and inspiration in, science careers -- jobs that are pertinent in building a brighter future for us all."

According to a 2007 study, roughly one in four new teachers in Illinois leave their teaching careers during their first five years and do not return(1). In an effort to help address the issue of teacher attrition, the NSTA created the New Science Teacher Academy, a professional development initiative designed to help promote quality science teaching, enhance teacher confidence and classroom excellence, and improve teacher content knowledge. The program uses mentoring and other professional development resources to support new science teachers during the often challenging, initial teaching years and to encourage them to stay in the profession.

"The ability to learn and develop exceptional teaching skills throughout a teaching career can have a profound effect on the quality of the teaching force and the performance of students," said Dr. Francis Eberle, executive director, NSTA. "We remained thrilled at the results we see each year and are grateful to have continued support from industry leaders, like Astellas, for this critical program."

For more information about the New Science Teacher Academy, or to learn how to apply, please visit www.nsta.org/academy.

About NSTA

The Arlington, VA-based National Science Teachers Association (www.nsta.org) is the largest professional organization in the world promoting excellence and innovation in science teaching and learning for all. NSTA's current membership includes more than 60,000 science teachers, science supervisors, administrators, scientists, business and industry representatives, and others involved in science education. The New Science Teacher Academy was created as part of NSTA's John Glenn Center for Science Education Campaign.

About Astellas

Astellas' culture and brand is committed to building community, helping others, encouraging integrity and inspiring people to make a difference, today, tomorrow and every day.

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, inc., please visit our website at www.astellas.us

(1) Karen J. DeAngelis and Jennifer B. Presley, Illinois Education Research Council Symposium June 7-8, 2007, Leaving Schools or Leaving the Profession: Setting Illinois' Record Straight on New Teacher Attrition


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chicago Mayor Honors Astellas Excellence in Learning, Development
2. Update on Astellas Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
3. Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition
4. Astellas Seeks Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
5. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
6. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
7. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
8. Astellas Names Head of Global R&D Operations
9. Astellas Adds CNS Therapy Area Leader to Global R&D Team
10. Astellas Hires New Vice President of Compliance
11. Astellas Announces New Vice President of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... System and David Konur, CEO of Cardiovascular Institute of the South announced today ... be performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, ... Blue Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and ... Company; Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession of Aging ... our aging population has on communities and resources. Aging Life Care plays an important ... age-related challenges. , Aging Life Care is a holistic, client-centered approach to caring ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. ... announced a development collaboration with the Australian critical medicine company, Phebra Pty ... schizophrenia. , LAI medicines can offer improved therapeutic benefits over oral formulations, including ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... for electronic cigarettes, requiring e-cigarette manufacturers to submit their products through an arduous ... to all vaping products that entered the market since February 15, 2007. That ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocythemia Market and ... to their offering.       ... ,The latest research Europe Thrombocythemia Market ... provides comprehensive insights into Thrombocythemia pipeline ...
(Date:5/4/2016)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... First Quarter 2016 Highlights , Generated ... "Cash Flow") of $13.6 million for the first quarter ... million for the first quarter of 2016; , ...
(Date:5/4/2016)... 2016 According to market research "Global ... Forecast to 2022 - Industry Insights by Slice Type (High, ... Others)" by P&S Market Research, the global computed tomography ... it is expected to grow at a CAGR of 5.0% ... segment is expected to witness the faster growth, CAGR of ...
Breaking Medicine Technology: